PATENT CLAIM ANALYSIS

Application Number: 15879143
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["514", "532000"]

Abstract:
The invention provides methods of synthesizing the purified enantiomers of oleocanthal. The invention further provides methods of using oleocanthals in various formulations including, food additives; pharmaceuticals; cosmetics; animal repellants; and discovery tools for mammalian irritation receptor genes, gene products, alleles, splice variants, alternate transcripts and the like.

Claim (Index 1):
A method of treating a patient with an inflammatory disorder comprising administering to a patient with an inflammatory disorder an effective amount of a composition comprising a compound of the formula: wherein: R1 and R4 are independently H or \u2014OR5; R2 and R3 are independently CHO or COOR5; R5 is a H, C 1 -C 5  alkyl, or a glycoside; X is O, NH or CH 2 ; Y is C\u2550CHCH 3  or CH\u2014COOR5; Z is C\u2550O or CH\u2014OR5; A is CH 2  or CH\u2014COOR5; wherein said composition alleviates inflammation in said patient.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 86.0
- Lexical Diversity: 1.38095
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12597053', '14271884', '14934888', '15269069', '12814190']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6634318962437808
- 35 USC 102 Novelty (BERT): 0.5113417832668136
- Combined Prediction Score: 0.6482228849460842
- Mean Citation Score: 136.80057
- Max Citation Score: 248.25418
- Similarity Product: 171.8368539693927

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test